AFME — Affluent Medical SAS Share Price
0.000.00%
Last trade - 00:00- €61.49m
- €70.90m
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | n/a | ||
| PEG Ratio (f) | n/a | ||
| EPS Growth (f) | n/a | ||
| Dividend Yield (f) | n/a | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | 1.58 | ||
| Price to Tang. Book | n/a | ||
| Price to Free Cashflow | n/a | ||
| Price to Sales | n/a | ||
| EV to EBITDA | n/a | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | -25.49% | ||
| Return on Equity | -40.37% | ||
| Operating Margin | n/a | ||
Financial Summary
| Year End 31st Dec | Unit | 2018 | 2019 | 2020 | 2021 | 2022 | 2023E | 2024E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | €m | 0.04 | n/a | n/a | n/a | n/a | n/a | n/a | -100% |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
Affluent Medical SAS is a France-based company that manufactures surgical implants. It designs minimally invasive prostheses at mimicking human anatomy and restoring native physiology for critical functions in cardiovascular and urological therapies. It provides several products such as Kalios, Epygon, Artus. It helps in treating heart disease and urinary incontinence. The Company provides transcatheter and flow control technologies, such as mimicry of anatomy and restoration of physiology minimally invasive implant procedures, optimized and biocompatible components.
Directors
- Michel Finance CHM
- Jerome Geoffroy CFO
- Olivier Pierron COO (45)
- Eric Jague OTH
- Francois Laborde OTH
- Pascale Lagrange OTH
- Claire Corot DRC
- Patrick Coulombier DRC
- Daniel Hayoz DRC
- Philippe Pouletty DRC (64)
- Dominique Carouge IND
- Soad Ghazouani IND
- Veronique Phe IND
- Ellen Roche IND
- Last Annual
- December 31st, 2022
- Last Interim
- June 30th, 2023
- Incorporated
- February 6th, 2018
- Public Since
- June 14th, 2021
- No. of Employees
- 52
- Sector
- Healthcare Equipment & Supplies
- Industry
- Healthcare
- Exchange
- Euronext - Paris
- Shares in Issue
- 30,899,458
- Address
- 320 avenue Archimede, AIX-EN-PROVENCE, 13100
- Web
- https://www.affluentmedical.com/
- Phone
- +33 442951220
- Contact
- Sebastien Ladet
- Auditors
- PricewaterhouseCoopers Audit
Upcoming Events for AFME
Similar to AFME
Alpha MOS SA
Euronext - Paris
Amplitude Surgical SA
Euronext - Paris
Biomerieux SA
Euronext - Paris
Biosynex SA
Euronext - Paris
Bluelinea SA
Euronext - Paris
FAQ
What is the Affluent Medical SAS share price?
As of Today at 19:00 UTC, shares in Affluent Medical SAS are trading at €1.99. This share price information is delayed by 15 minutes.
How has the Affluent Medical SAS share price performed this year?
Shares in Affluent Medical SAS last closed at €1.99 and the price had moved by +54.26% over the past 365 days. In terms of relative price strength the Affluent Medical SAS share price has outperformed the FTSE Global All Cap Index by +42.29% over the past year.
What are the analyst and broker recommendations for Affluent Medical SAS?
The overall consensus recommendation for Affluent Medical SAS is Strong Buy. You can view the full broker recommendation list by unlocking its StockReport.
What is the Affluent Medical SAS dividend yield?
Affluent Medical SAS does not currently pay a dividend.
Does Affluent Medical SAS pay a dividend?
Affluent Medical SAS does not currently pay a dividend.
When does Affluent Medical SAS next pay dividends?
Affluent Medical SAS does not currently pay a dividend.
How do I buy Affluent Medical SAS shares?
To buy shares in Affluent Medical SAS you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
What is the market cap of Affluent Medical SAS?
As of the previous close price of €1.99, shares in Affluent Medical SAS had a market capitalisation of €61.49m.
Where are Affluent Medical SAS shares listed?
Here are the trading details for Affluent Medical SAS:
- Country of listing: France
- Exchange: PAR
- Ticker Symbol: AFME
What kind of share is Affluent Medical SAS?
Based on an overall assessment of its quality, value and momentum Affluent Medical SAS is currently classified as a Momentum Trap. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
Is there a Affluent Medical SAS share price forecast for 2024?
The analyst consensus target price for shares in Affluent Medical SAS is €3.50. That is 75.88% above the last closing price of €1.99.
Analysts covering Affluent Medical SAS currently have a consensus Earnings Per Share (EPS) forecast of -€0.60 for the next financial year.
What is the trend in the Affluent Medical SAS share price?
An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Affluent Medical SAS. Over the past six months, its share price has outperformed the FTSE Global All Cap Index by +75.14%.
As of the last closing price of €1.99, shares in Affluent Medical SAS were trading +46.28% higher than their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
What is the Affluent Medical SAS PE Ratio?
The Affluent Medical SAS PE ratio based on its reported earnings over the past 12 months is null. The shares last closed at €1.99.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Who are the key directors of Affluent Medical SAS?
Affluent Medical SAS' management team is headed by:
- Michel Finance - CHM
- Jerome Geoffroy - CFO
- Olivier Pierron - COO
- Eric Jague - OTH
- Francois Laborde - OTH
- Pascale Lagrange - OTH
- Claire Corot - DRC
- Patrick Coulombier - DRC
- Daniel Hayoz - DRC
- Philippe Pouletty - DRC
- Dominique Carouge - IND
- Soad Ghazouani - IND
- Veronique Phe - IND
- Ellen Roche - IND